Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-01
1999-03-23
Travers, Russell
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514370, A61K 31425
Patent
active
058860134
ABSTRACT:
The present invention relates to a pharmaceutical composition containing a compound of formula I ##STR1## with one of the symbols R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5 representing OH, whereas the remaining symbols represent H as antiviral agent.
REFERENCES:
patent: 2132431 (1973-01-01), Grafe et al.
patent: 4315018 (1982-02-01), Rossignol
patent: 4962117 (1990-10-01), Young et al.
patent: 5314889 (1994-05-01), Boigegrain et al.
R. Cavier et al., "Recherches sur les derives nitres d'interret biologique ", European Journal of Medicinal Chemistry , Chimica, Therapeutica, vol. 13, no. 6, 1978 Paris FR. pp. 539-543.
M. Dymicky et al., "Inhibition of Clostridium botulinum by 5-Nitrothiazolas ", Antimicrobial Agents & Chemotherapy , vol. 12, No. 3, Sep. 1997 Washington D.C., pp. 353-356
Murphy et al., 1985, 102CA197602b.
Husain et al., 1980, 93CA:114374a.
Miller et al., 1991, 115CA201741j.
Romark Laboratories, L.C.
Travers Russell
LandOfFree
Antiviral composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2125716